Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.53.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.47.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used